Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Retrosuperior costotransverse ligament block group, Erector spinae block group.
- Who it may be relevant to
- Registry conditions: Perioperative Analgesia. Basic parameters: 21 years — 64 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy: A Randomized Clinical Trial.
Overview
This study aims to compare the analgesic effect of retro superior costotransverse ligament space block vs erector spinae plane block to Achieve high-quality perioperative opioid-sparing effect and postoperative analgesia after laparoscopic cholecystectomy with optimum hemodynamic stability and high patient and surgeon satisfaction
Detailed description
This study aims to compare between retro superior costotransverse ligament space block vs erector spinae plane block
* To compare the analgesic outcomes (time to first analgesic request, total amount of analgesic consumption and pain scores by NRS) * To assess the block performance time required to perform each technique . * To compare intraoperative parameters (hemodynamics and intraoperative fentanyl consumption) * To assess patient, surgeon satisfaction and complications of the block.
Interventions
- Procedure Retrosuperior costotransverse ligament block group
The patient will receive retrosuperior costotransverse ligament block - Procedure Erector spinae block group
The patient will receive erector spinae block.
Primary outcome measures
- The time to first call to rescue analgesia [Time frame: 24 hours]
Secondary outcome measures (7)
- To assess block characteristics (block performance time) [Time frame: 1 hour]
- Total intraoperative fentanyl consumption [Time frame: duration of surgery (up to 2 hours)]
- Pain intensity by Numerical Rating Scale [Time frame: 30 minutes after arrival to post anesthesia care unit , 2hours, 4hours, 6hours, 8hours, 12hours, 18 hours and 24hours postoperative]
- total amount of rescue analgesia [Time frame: 24 hours]
- Intraoperative hemodynamics (Heart Rate and Mean Arterial Pressure) [Time frame: every 5 minutes in the first 30 minutes then every 10 minutes till the end of surgery]
- Patient's satisfaction [Time frame: 24 hours]
- complication of the block [Time frame: 24 hours]
Eligibility criteria
Inclusion criteria
- patient acceptance
- Age: 21-64 years old.
- Sex: both sexes.
- Physical status: ASA I \& II.
- Body mass index (BMI): 18.5 - 30 kg/m2.
- Type of operations: elective laparoscopic cholecystectomy.
- Duration of surgery not more than 2 hours.
Exclusion criteria
- Known hypersensitivity to lidocaine or bupivacaine.
- Patients with respiratory insufficiency.
- Coagulation disorders or taking drugs affect surgical hemostasis.
7\. Patients with pre-existing neurological deficits. 8. Uncooperative patient or with altered mental status. 9. Patient with advanced cardiovascular or respiratory diseases
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Faculty of human medicine, Zagazig university, Zagazig — Zagazig
Identifiers
NCT: NCT07276646 · 1783